C
ISSUER//CIK 0001337223
CytRx Oncology Corp
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 10-K/A210.8 KBInnovive Pharmaceuticals, Inc.Apr 29, 3:45 PM ET·0000950123-08-004833
- 48.9 KBInnovive Pharmaceuticals, Inc.Jul 12, 4:47 PM ET·0001181431-07-045404
- 49.5 KBInnovive Pharmaceuticals, Inc.Jul 12, 4:46 PM ET·0001181431-07-045403
- 8-K13.1 KBInnovive Pharmaceuticals, Inc.May 11, 1:48 PM ET·0000950123-07-007280
- 8-K281.3 KBInnovive Pharmaceuticals, Inc.Apr 25, 1:42 PM ET·0000950123-07-005965
- 8-K38.3 KBInnovive Pharmaceuticals, Inc.Oct 13, 4:59 PM ET·0001193125-06-207685
- 8-K45.3 KBInnovive Pharmaceuticals, Inc.Jul 18, 3:25 PM ET·0001193125-06-148399
- 46.8 KBInnovive Pharmaceuticals, Inc.Jul 17, 4:56 PM ET·0001181431-06-042304
- 33.9 KBInnovive Pharmaceuticals, Inc.Jul 17, 4:55 PM ET·0001181431-06-042303
Insiders
1Tickers
No tickers on record
Addresses
business
555 MADISON AVENUE, 25TH FLOOR
NEW YORK, NY, 10022
mailing
555 MADISON AVENUE, 25TH FLOOR
NEW YORK, NY, 10022
Former Names
- Innovive Pharmaceuticals, Inc.2008-08-14